Filana Therapeutics (FLNA) Current Assets (2010 - 2026)
Filana Therapeutics (FLNA) posted quarterly Current Assets of $83.7 million for Q2 2026, down 27.08% year-over-year from $114.8 million in Q2 2025, and down 4.82% quarter-over-quarter from $88.0 million in Q1 2026.
Filana Therapeutics (FLNA) Current Assets (2010 - 2026) Analysis & Trends
Filana Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $83.7 million for Q2 2026.
- In Q2 2026, Current Assets fell 27.08% year-over-year to $83.7 million; the TTM figure through Jun 2026 stood at $83.7 million (down 27.08% YoY), while the FY2025 annual figure was $97.7 million, down 28.44% from the prior year.
- Current Assets for Q2 2026 stood at $83.7 million, down from $88.0 million in the prior quarter.
- The five-year high for Current Assets was $222.2 million in Q1 2022, with the low at $83.7 million in Q2 2026.
- The 5-year median for Current Assets is $143.4 million (2023), against an average of $154.4 million.
- The sharpest annual moves came in 2024 and 2025: Current Assets soared 34.87% in 2024, then slumped 48.31% in 2025.
- Filana Therapeutics' Current Assets stood at $211.2 million in 2022, then tumbled by 38.63% to $129.6 million in 2023, then gained by 5.32% to $136.5 million in 2024, then fell by 28.44% to $97.7 million in 2025, then fell by 14.31% to $83.7 million in 2026.
- Business Quant data shows FLNA's Current Assets at $83.7 million in Q2 2026, $88.0 million in Q1 2026, and $97.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.82 Bn | 131.97 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.70 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.23 Bn | 60.05 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 60.16 Bn | 55.02 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.07 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.86 Bn | 28.55 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.24 Bn | 9.85 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | Filana Therapeutics | 46.10 Mn | 46.10 Mn | - | 83.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 83.72 Mn |
| Mar 31, 2026 | 87.96 Mn |
| Dec 31, 2025 | 97.71 Mn |
| Sep 30, 2025 | 108.91 Mn |
| Jun 30, 2025 | 114.82 Mn |
| Mar 31, 2025 | 120.15 Mn |
| Dec 31, 2024 | 136.53 Mn |
| Sep 30, 2024 | 202.55 Mn |
| Jun 30, 2024 | 222.12 Mn |
| Mar 31, 2024 | 134.00 Mn |
| Dec 31, 2023 | 129.63 Mn |
| Sep 30, 2023 | 150.18 Mn |
| Jun 30, 2023 | 174.53 Mn |
| Mar 31, 2023 | 195.00 Mn |
| Dec 31, 2022 | 211.23 Mn |
| Sep 30, 2022 | 183.27 Mn |
| Jun 30, 2022 | 204.20 Mn |
| Mar 31, 2022 | 222.20 Mn |
| Dec 31, 2021 | 244.48 Mn |
| Sep 30, 2021 | 251.92 Mn |